Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
![]() |
![]() ![]() |
Ultima descărcare din IBN: 2023-09-13 16:42 |
![]() MACH, Francois, BAIGENT, Colin N., CATAPANO, Alberico L., NOI, Autori, IVANOV, Victoria. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular riskErratum in:Corrigendum to: 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.. In: European Heart Journal, 2020, vol. 41, pp. 140-205. ISSN 0195-668X. DOI: https://doi.org/10.1093/eurheartj/ehz455 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
European Heart Journal | ||||||
Volumul 41 / 2020 / ISSN 0195-668X | ||||||
|
||||||
DOI:https://doi.org/10.1093/eurheartj/ehz455 | ||||||
Pag. 140-205 | ||||||
|
||||||
![]() |
||||||
Cuvinte-cheie adult, Aged, biomarkers, cardiovascular diseases, consensus, drug therapy, Combination, dyslipidemias, female, Humans, Hypolipidemic Agents, lipids, Male, middle aged, risk assessment, risk factors, Risk Reduction Behavior, treatment outcome |
||||||
|
Dublin Core Export
<?xml version='1.0' encoding='utf-8'?> <oai_dc:dc xmlns:dc='http://purl.org/dc/elements/1.1/' xmlns:oai_dc='http://www.openarchives.org/OAI/2.0/oai_dc/' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd'> <dc:creator>MacH, F.</dc:creator> <dc:creator>Baigent, C.</dc:creator> <dc:creator>Catapano, A.</dc:creator> <dc:creator>Noi, A.</dc:creator> <dc:creator>Ivanov, V.M.</dc:creator> <dc:date>2020-01-01</dc:date> <dc:identifier>10.1093/eurheartj/ehz455</dc:identifier> <dc:source>European Heart Journal () 140-205</dc:source> <dc:subject>adult</dc:subject> <dc:subject>Aged</dc:subject> <dc:subject>biomarkers</dc:subject> <dc:subject>cardiovascular diseases</dc:subject> <dc:subject>consensus</dc:subject> <dc:subject>drug therapy</dc:subject> <dc:subject>Combination</dc:subject> <dc:subject>dyslipidemias</dc:subject> <dc:subject>female</dc:subject> <dc:subject>Humans</dc:subject> <dc:subject>Hypolipidemic Agents</dc:subject> <dc:subject>lipids</dc:subject> <dc:subject>Male</dc:subject> <dc:subject>middle aged</dc:subject> <dc:subject>risk assessment</dc:subject> <dc:subject>risk factors</dc:subject> <dc:subject>Risk Reduction Behavior</dc:subject> <dc:subject>treatment outcome</dc:subject> <dc:title>2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular riskErratum in:Corrigendum to: 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.</dc:title> <dc:type>info:eu-repo/semantics/article</dc:type> </oai_dc:dc>